Skip to the main street
New Biz Launchesnewly opened
Sign in

PepGuard vs DrugCard

A side-by-side comparison built from both listings. Blank cells mean the company has not given that detail; we never guess.

PepGuard compared with DrugCard
DetailPepGuard logo PepGuardDrugCard logo DrugCard
What it doesAI-powered peptide safety analysis against published evidence AI-powered pharmacovigilance automation for global and local literature monitoring and regulatory intelligence
StageNot given Established
FoundedNot given 2019
Based inNot given EE
Pricing modelPaid Not given
PricingStarter: $15/mo (100 checks/month, 1 stack). Pro: $19/mo (125 checks/month, 3 stacks, stack interaction analysis, PDF export). Clinic: $25/mo (165 checks/month, 10 stacks, stack interaction analysis, PDF export, priority support). Weekly and monthly billing cycles available. Not given
Key features
  • AI-powered safety scoring weighted by study design and sample size
  • Regulatory status lookup for US FDA approvals and investigational status
  • Peptide stack builder with dosing calendar and adherence tracking
  • Stack interaction analysis across multiple compounds
  • PDF export of full reports
  • Mobile app label scanning capability
  • Real-time evidence retrieval from three primary sources
  • Risk flag identification for specific peptides
  • Automated literature monitoring across 100+ languages
  • Coverage of 151+ countries and 2300+ local medical journals
  • OCR technology with 99% accuracy for scanned texts
  • Regulatory intelligence tracking
  • Adverse event database and case management
  • AI Case Intake module for automated data extraction
  • PSUR and PBRER automation
  • Weekly and instant email notifications
  • Signal detection capabilities
  • Integration with safety database for auto-population
What makes it different
  • No vendor spin or cherry-picked studies in reports
  • Evidence scored by research quality, not advertising budget
  • Covers 29 peptide compounds with detailed analysis
  • Results delivered in seconds with full source traceability
  • No medical advice: pure research summarization tool
  • Covers 100+ languages and 2300+ local journals globally
  • Achieves 50-70% time savings versus manual screening
  • Discovers 3-5x more relevant hits than manual approaches
  • Proprietary AI and OCR technology with 99% accuracy
  • Quick onboarding and deployment within 2 business days
Community votes00
DR (Domain Rating by Ahrefs)Not checked yet no change since last check44 +1 (up) since last check
Trust Flow (Majestic)012
Citation Flow (Majestic)1032
Referring domains (Majestic)11194

3 details filled in for both companies.

More alternatives to PepGuard More alternatives to DrugCard

Support